Clinical Research Quality "Report Cards" May Be Considered By FDA
Executive Summary
Clinical trial research quality "report cards" are one idea FDA could consider to help determine the extent of problems with clinical trial research quality, Center for Devices & Radiologic Health Director David Feigal, MD, told a Food & Drug Law Institute meeting June 5 in Washington, D.C.